1Yang WY, Lu JM, Weng JP,eZ al. Prevalence of diabetes among men and women in china[J]. N Engl J Med,2010,362( 12) :1090-1101.
2Noto H, Tsujimoto T, Sasazuki T,et al. Significantly increased risk of cancer in patients with diabetes mellitus: A systematic review and meta-analysis [J]. Endocr Pract,2011,17(4) *? 616-628.
3Grote VA,Becker S, Kaaks R,et al. Diabetes mellitus type 2-an independent risk factor for cancer[ J]. Exp Clin Endocrinol Diabetes,2010,118(1):4-8.
4Barone BB, Yeh HC, Snyder CF,ei al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic reviewand meta-analysis[ J]. JAMA,2008, 300(23) : 2754-2764.
5Lam EK,Batty GD,Huxleyal. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region[ J]. Ann On-col,2011,22(3) :730-738.
6Jiang Y,Ben Q, Shen H,ei al. Diabetes mellitus and incidence and mortality of colorectal cancer: A systematic review and meta-analysis of cohortstudies[ J]. Eur J Epidemiol,2011,26(11) :863-876.
7Mussig K, Staiger H, Kantartzis K,et al. Type 2 diabetes mellitus and risk of malignancy: Is there a strategy to identify a subphenotype of pa-tients with increased susceptibility to endogenous and exogenous hyperinsulinism[ J]. Diabet Med,2011,28(3) :276-286.
8Schiel R,Miiller UA,Braun A,et al. Risk of malignancies in patients with insulin treated diabetes mellitus: Results of a population based trialwith 10 year follow up (JEVIN) [ J]. Eur J Med Res, 2005, 10(8): 339-344.
9Rowker SL,Majumdar SR,Veugelers P,et al. Increased cancer related mortality for patients with type 2 diabetes who use sulfonylureas or insulin[J]. Diabetes Care, 2006, 29(2) ; 254-258.
10von Kriegstein E, von Kriegstein K. Inhaled insulin for diabetes mellitus[ J]. N Engl J Med, 2007,356(20) :2106-2110.
